A Retrospective Study of Clinical Pathways and Outcomes of Andexanet Alfa Administration for Reversal of Critical Bleeding or Urgent Surgery in Patients on Oral Direct Factor Xa Inhibitors

被引：0
|
作者：
Goldin, Mark
Smith, Kolton
Koulas, Ioannis
Leung, Tung Ming
Ravi, Mayuri
Parhar, Sanjit
Shah, Sejal
Floyd, Kayla
Ohanesian, Lori
Bain, Rachel
Defonte, Daniella
Ochani, Kanta
Spyropoulos, Alex
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Anticoagulation; Thrombosis; Vascular; Progenitor cell;
D O I：
10.1161/circ.148.suppl_1.15557
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A15557
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Administration of 4-Factor Prothrombin Complex Concentrate as an Antidote for Intracranial Bleeding in Patients Taking Direct Factor Xa Inhibitors
    Grandhi, Ramesh
    Newman, W. Christopher
    Zhang, Xiaoran
    Harrison, Gillian
    Moran, Colleen
    Okonkwo, David O.
    Ducruet, Andrew F.
    WORLD NEUROSURGERY, 2015, 84 (06) : 1956 - 1961
  • [32] Enoxaparin is not an oral factor Xa inhibitor. Response to Sutton et al. real-world clinical outcomes among US veterans with oral factor Xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate
    Buka, Richard J.
    Sutton, David J.
    Nicolson, Phillip L. R.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (04) : 739 - 741
  • [33] Effect of PCC on Thrombin Generation among Patients on Factor Xa Inhibitors with Major Bleeding or Needing Urgent Surgery (GAUGE): Design and Rationale
    Shaw, Joseph R.
    Unachukwu, Ubabuko
    Cyr, Joseph
    Siegal, Deborah M.
    Castellucci, Lana A.
    Van Dreden, Patrick
    Dowlatshahi, Dar
    Buyukdere, Hakan
    Ramsay, Timothy
    Carrier, Marc
    TH OPEN, 2023, 07 (03) : e229 - e240
  • [34] Surgery and invasive procedures in patients on long-term treatment with oral direct thrombin or factor Xa inhibitors
    Sie, P.
    Samama, C. -M.
    Godier, A.
    Rosencher, N.
    Steib, A.
    Llau, J. -V.
    van der Linden, P.
    Pernod, G.
    Lecompte, T.
    Gouin-Thibault, I.
    Albaladejo, P.
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2011, 30 (09): : 645 - 650
  • [35] Surgery and invasive procedures in patients on long term treatment with oral direct thrombin or factor Xa inhibitors (update 2012)
    Sie, Pierre
    Samama, Charles Marc
    Godier, Anne
    Rosencher, Nadia
    Steib, Annick
    Llau, Juan V.
    van der Linden, Philippe
    Pernod, Gilles
    Lecompte, Thomas
    Gouin-Thibault, Isabelle
    Albaladejo, Pierre
    SANG THROMBOSE VAISSEAUX, 2012, 24 (06): : 269 - 278
  • [36] Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate (Vol 56, pg 137, 2023)
    Sutton, S. Scott
    Magagnoli, Joseph
    Cummings, Tammy H. H.
    Dettling, Theresa
    Lovelace, Belinda
    Christoph, Mary J. J.
    Hardin, James W. W.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 56 (02) : 360 - 360
  • [37] Platelet Aggregation in Direct Oral Factor Xa Inhibitors-treated Patients With Atrial Fibrillation: A Pilot Study
    Banovcin, Peter
    Skornova, Ingrid
    Samos, Matej
    Schnierer, Martin
    Bolek, Tomas
    Kovar, Frantisek
    Stasko, Jan
    Kubisz, Peter
    Mokan, Marian
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2017, 70 (04) : 263 - 266
  • [38] Clinical and Economic Consequences of a First Major Bleeding Event in Patients Treated with Direct Factor Xa Inhibitors in Spain: A Long-Term Observational Study
    Escobar, Carlos
    Palacios, Beatriz
    Villarreal, Miriam
    Gutierrez, Martin
    Capel, Margarita
    Aranda, Unai
    Hernandez, Ignacio
    Garcia, Maria
    Lledo, Laura
    Arenillas, Juan F.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (14)
  • [39] Outcomes with direct-acting oral anticoagulants in patients with a history of bariatric surgery: a retrospective cohort study
    Langworthy, Diana R.
    Schullo-Feulner, Anne M.
    Gannon, Erica
    Fijalka, Andrew
    Czycalla, Christine
    Palzer, Elise F.
    Brearly, Ann
    Shah, Surbhi
    SURGERY FOR OBESITY AND RELATED DISEASES, 2023, 19 (03) : 222 - 230
  • [40] SAFETY OF THE CONCURRENT USE OF FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE WITH ANDEXANET ALFA FOR REVERSAL OF FACTOR XA INHIBITOR-RELATED BLEEDING: A RETROSPECTIVE CASE SERIES PARDIS NIAMI, PHARMD, AND TODD E. H. HECHT, MD, FACP, SFHM
    Niami, Pardis
    Hecht, Todd
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E79 - E79
12345